THE NICKLES GROUP, LLC

View full entity profile (contributions, contracts, SEC) →

Lobbying Income

$167.6M

Filings

3,044

Unique Clients

Active Period

2005–2026

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2026	$9,135,000	169	57
2025	$11,510,000	214	52
2024	$9,230,000	175	44
2023	$8,180,000	159	39
2022	$7,770,000	158	39
2021	$7,090,000	141	39
2020	$7,810,000	154	39
2019	$7,680,000	154	40
2018	$7,715,246	139	35
2017	$7,981,995	143	35
2016	$6,660,996	129	35
2015	$7,395,000	138	36
2014	$7,824,250	145	38
2013	$8,197,350	143	37
2012	$8,374,280	141	35
2011	$8,036,477	153	39
2010	$6,642,700	126	33
2009	$7,196,650	129	30
2008	$8,583,400	154	35
2007	$6,506,250	68	32
2006	$5,494,000	55	30
2005	$2,540,000	57	25

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
AMERICAN HOSPITAL ASSOCIATION	$6,759,000	86	2005–2026
WALMART INC	$5,530,000	66	2010–2026
FEDERAL EXPRESS CORPORATION	$4,565,000	78	2007–2026
CLEVELAND CLINIC FOUNDATION	$4,362,650	82	2005–2026
BAXTER HEALTHCARE CORPORATION	$4,281,000	81	2006–2026
COMCAST CORPORATION	$4,210,000	80	2005–2026
BRISTOL-MYERS SQUIBB COMPANY	$4,160,000	65	2005–2021
AMERICAN DENTAL ASSOCIATION	$4,132,500	81	2008–2026
CIGNA CORPORATION	$4,056,000	68	2007–2023
ORACLE CORPORATION	$4,035,000	46	2015–2026
MERCHANTS PAYMENTS COALITION INC	$3,942,500	79	2008–2026
ANADARKO PETROLEUM CORPORATION (FORMERLY KERR MCGEE CORPORATION)	$3,780,000	54	2006–2019
INTELLECTUAL VENTURES	$3,598,000	38	2005–2015
UCB, INC.	$3,572,500	60	2012–2026
MEDTRONIC	$3,229,300	56	2005–2019
AMERICAN SOCIETY OF ANESTHESIOLOGISTS	$3,160,000	65	2005–2021
EXXON MOBIL CORPORATION	$3,104,500	52	2006–2019
GENERAL MOTORS LLC	$3,030,000	39	2005–2015
OMEROS CORPORATION	$2,705,000	41	2017–2026
HOSPICE ACTION NETWORK	$2,668,237	60	2011–2024
SMITH & NEPHEW INC	$2,555,000	50	2014–2026
L3 HARRIS TECHNOLOGIES	$2,442,500	36	2018–2026
COMPETE	$2,370,000	28	2005–2012
MANAGEMENT HEALTH SYSTEMS, LLC (D/B/A MEDPRO)	$2,250,000	31	2019–2026
QUALITY DIABETES CARE COALITION	$2,000,000	28	2008–2013

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	2,750
HOUSE OF REPRESENTATIVES	2,660
Health & Human Services, Dept of (HHS)	544
Centers For Medicare and Medicaid Services (CMS)	406
Executive Office of the President (EOP)	317
White House Office	173
Office of Management & Budget (OMB)	170
Homeland Security, Dept of (DHS)	104
Food & Drug Administration (FDA)	60
Treasury, Dept of	60
State, Dept of (DOS)	30
Commerce, Dept of (DOC)	29
U.S. Trade Representative (USTR)	29
Veterans Affairs, Dept of (VA)	29
Energy, Dept of	27
Defense, Dept of (DOD)	26
Natl Economic Council (NEC)	26
Federal Emergency Management Agency (FEMA)	24
Federal Communications Commission (FCC)	19
Natl Institutes of Health (NIH)	15

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	1,379
Medicare/Medicaid	Medicare/Medicaid	1,377
Health Issues	Health Issues	1,298
Budget/Appropriations	Budget/Appropriations	782
Copyright/Patent/Trademark	Copyright/Patent/Trademark	319
Defense	Defense	312
Trade (domestic/foreign)	Trade (domestic/foreign)	293
Energy/Nuclear	Energy/Nuclear	248
Homeland Security	Homeland Security	223
Labor Issues/Antitrust/Workplace	Labor Issues/Antitrust/Workplace	217
Banking	Banking	180
Immigration	Immigration	141
Veterans	Veterans	139
Science/Technology	Science/Technology	136
Government Issues	Government Issues	131
Communications/Broadcasting/Radio/TV	Communications/Broadcasting/Radio/TV	126
Aviation/Airlines/Airports	Aviation/Airlines/Airports	114
Small Business	Small Business	101
Environment/Superfund	Environment/Superfund	101
Law Enforcement/Crime/Criminal Justice	Law Enforcement/Crime/Criminal Justice	99

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2026 · third_quarter · Client: AMGEN

Open original LDA filing ↗

Cited source text and reported amounts

Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1

S. 1954119th Congress

Biosimilar Red Tape Elimination Act

2026 · third_quarter · Client: AMGEN

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to pharmacy benefit management reforms. Issues related to cardiovascular care. Issues related to drug pricing. Issues related to the drug supply chain. S. 3788, Clear Labels Act. S. 3014, Ensuring Timely Access to Generics Act of 2025; S. 1954, Biosimilar Red Tape Elimination Act; S. 2658, Medication Affordability and Patent Integrity Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 1954

S. 2658119th Congress

Medication Affordability and Patent Integrity Act

2026 · third_quarter · Client: AMGEN

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to pharmacy benefit management reforms. Issues related to cardiovascular care. Issues related to drug pricing. Issues related to the drug supply chain. S. 3788, Clear Labels Act. S. 3014, Ensuring Timely Access to Generics Act of 2025; S. 1954, Biosimilar Red Tape Elimination Act; S. 2658, Medication Affordability and Patent Integrity Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 2658

S. 3014119th Congress

Ensuring Timely Access to Generics Act of 2025

2026 · third_quarter · Client: AMGEN

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to pharmacy benefit management reforms. Issues related to cardiovascular care. Issues related to drug pricing. Issues related to the drug supply chain. S. 3788, Clear Labels Act. S. 3014, Ensuring Timely Access to Generics Act of 2025; S. 1954, Biosimilar Red Tape Elimination Act; S. 2658, Medication Affordability and Patent Integrity Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 3014

Show 21 more cited filings

S. 3788119th Congress

CLEAR LABELS Act

2026 · third_quarter · Client: AMGEN

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to pharmacy benefit management reforms. Issues related to cardiovascular care. Issues related to drug pricing. Issues related to the drug supply chain. S. 3788, Clear Labels Act. S. 3014, Ensuring Timely Access to Generics Act of 2025; S. 1954, Biosimilar Red Tape Elimination Act; S. 2658, Medication Affordability and Patent Integrity Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 3788

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2026 · third_quarter · Client: KOCH GOVERNMENT AFFAIRS, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to partnership regulations. Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and energy taxes.

Client expense: — · Firm income: $80,000

Matched citations: H.R. 1

H.R. 1346119th Congress

To amend the Clean Air Act with respect to the ethanol waiver for Reid Vapor Pressure under that Act, and for other purposes.

2026 · third_quarter · Client: KOCH GOVERNMENT AFFAIRS, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fuels policy. H.R 1346, the Nationwide Consumer and Fuel Retailer Choice Act. Issues related to the TSCA Reauthorization legislation. S. 5526, Agricultural Act of 2026 and H.R. 7567, Farm, Food and National Security Act of 2026, as they relate to the renewable fuel standard.

Client expense: — · Firm income: $80,000

Matched citations: H.R 1346

H.R. 7567119th Congress

Farm, Food, and National Security Act of 2026

2026 · third_quarter · Client: KOCH GOVERNMENT AFFAIRS, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fuels policy. H.R 1346, the Nationwide Consumer and Fuel Retailer Choice Act. Issues related to the TSCA Reauthorization legislation. S. 5526, Agricultural Act of 2026 and H.R. 7567, Farm, Food and National Security Act of 2026, as they relate to the renewable fuel standard.

Client expense: — · Firm income: $80,000

Matched citations: H.R. 7567

S. 3841119th Congress

Last Sale Valuation Act of 2026

2026 · third_quarter · Client: KOCH GOVERNMENT AFFAIRS, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Monitor issues related to energy tariffs. S. 3841, Last Sale Valuation Act of 2026.

Client expense: — · Firm income: $80,000

Matched citations: S. 3841

S. 5526119th Congress

Agricultural Act of 2026

2026 · third_quarter · Client: KOCH GOVERNMENT AFFAIRS, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fuels policy. H.R 1346, the Nationwide Consumer and Fuel Retailer Choice Act. Issues related to the TSCA Reauthorization legislation. S. 5526, Agricultural Act of 2026 and H.R. 7567, Farm, Food and National Security Act of 2026, as they relate to the renewable fuel standard.

Client expense: — · Firm income: $80,000

Matched citations: S. 5526

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2026 · third_quarter · Client: BAXTER HEALTHCARE CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes. Monitor issues related to OECD Pillar 2.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 1

H.R. 5376119th Congress

Impacts and Outcomes for Health Career Training Act

2026 · third_quarter · Client: BAXTER HEALTHCARE CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Implementation of drug pricing provisions related to H.R. 5376 (P.L. 117-169), The Inflation Reduction Act. Issues related to safe mobility. Issues related to payment for prescription drugs. Issues concerning drug shortages.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 5376

H.R. 8800119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · third_quarter · Client: BAXTER HEALTHCARE CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act, as it relates to right to repair, and the ability of government contractors to pay dividends and buy back stock.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 8800

S. 4784119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · third_quarter · Client: BAXTER HEALTHCARE CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act, as it relates to right to repair, and the ability of government contractors to pay dividends and buy back stock.

Client expense: — · Firm income: $50,000

Matched citations: S. 4784

S. 4939119th Congress

Countering CCP Act

2026 · third_quarter · Client: BAXTER HEALTHCARE CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Monitored issues related to pharmaceutical prices. Issues regarding the pharmaceutical and medical device supply chain. Monitored issues concerning drug shortages. Issues concerning the reauthorization of Pandemic and All-Hazards Preparedness and Response Act (PAHPA). Monitored AI issues. Cybersecurity issues and S. 4939, Countering CCP Act. Issues concerning emergency preparedness and essential medical supplies. Issues concerning regulatory reforms.

Client expense: — · Firm income: $50,000

Matched citations: S. 4939

S. 4994119th Congress

ONSHORE Manufacturing Act

2026 · third_quarter · Client: BAXTER HEALTHCARE CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to tariffs. S. 4994, the ONSHORE Manufacturing Act.

Client expense: — · Firm income: $50,000

Matched citations: S. 4994

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2026 · third_quarter · Client: ORACLE CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Monitor implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes.

Client expense: — · Firm income: $90,000

Matched citations: H.R. 1

H.R. 2683119th Congress

Remote Access Security Act

2026 · third_quarter · Client: ORACLE CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to trade policy, including H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act and H.R. 2683 / S. 3519, Remote Access Security Act.

Client expense: — · Firm income: $90,000

Matched citations: H.R. 2683

H.R. 8800119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · third_quarter · Client: ORACLE CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to trade policy, including H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act and H.R. 2683 / S. 3519, Remote Access Security Act.

Client expense: — · Firm income: $90,000

Matched citations: H.R. 8800

H.R. 9340119th Congress

Ratepayer Protection Act

2026 · third_quarter · Client: ORACLE CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Issues relating to energy policy including H.R. 9340 / S. 5028, Ratepayer Protection Act.

Client expense: — · Firm income: $90,000

Matched citations: H.R. 9340

S. 3519119th Congress

Remote Access Security Act

2026 · third_quarter · Client: ORACLE CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to trade policy, including H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act and H.R. 2683 / S. 3519, Remote Access Security Act.

Client expense: — · Firm income: $90,000

Matched citations: S. 3519

S. 4784119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · third_quarter · Client: ORACLE CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to trade policy, including H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act and H.R. 2683 / S. 3519, Remote Access Security Act.

Client expense: — · Firm income: $90,000

Matched citations: S. 4784

S. 5028119th Congress

Ratepayer Protection Act

2026 · third_quarter · Client: ORACLE CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

Issues relating to energy policy including H.R. 9340 / S. 5028, Ratepayer Protection Act.

Client expense: — · Firm income: $90,000

Matched citations: S. 5028

H.R. 8800119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · third_quarter · Client: COMCAST CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

General telecommunications issues related to telecommunications and cable interests, including cyber security, rural broadband deployment, broadband adoption and digital literacy. H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act, as it relates to spectrum issues. Issues related to federal permitting reform.

Client expense: — · Firm income: $30,000

Matched citations: H.R. 8800

S. 4784119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · third_quarter · Client: COMCAST CORPORATION

Open original LDA filing ↗

Cited source text and reported amounts

General telecommunications issues related to telecommunications and cable interests, including cyber security, rural broadband deployment, broadband adoption and digital literacy. H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act, as it relates to spectrum issues. Issues related to federal permitting reform.

Client expense: — · Firm income: $30,000

Matched citations: S. 4784

Source: Senate LDA

THE NICKLES GROUP, LLC — Lobbying Disclosure | Poliscope